41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Dr. Gerald Dal Pan, Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research(United States Food and Drug Administration)
- Dr. Robert Temple, Deputy Center Director for Clinical Science, Center for Drug Evaluation and Research(United States Food and Drug Administration)
Meeting with interpretation and transcription